MedTrace Logo

FMT in the Treatment of IBS

NCT03561519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2018-08-15

No results posted yet for this study

Summary

52 adult IBS patients were recruited. 50% were given a fecal microbiota transplantation in colonoscopy and 50% were given an FMT made of their own feces as placebo. follow up time was 1 year after FMT.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Fecal Microbiota Transplantation (FMT)

Fecal suspension administered in colonoscopy into the cecum of the patient.

OTHER

Placebo

As a placebo a fecal suspension made of patients own feces is administered into the cecum of the patient in colonoscopy.

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Joint Authority for Päijät-Häme Social and Health Care

    lead OTHER

Principal Investigators

  • Perttu Arkkila, Adj. Prof. · +358 9 4711

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-27
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03561519 on ClinicalTrials.gov